FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:ACTR6-UHRF1BP1L

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: ACTR6-UHRF1BP1L
FusionPDB ID: 1884
FusionGDB2.0 ID: 1884
HgeneTgene
Gene symbol

ACTR6

UHRF1BP1L

Gene ID

64431

23074

Gene nameactin related protein 6UHRF1 binding protein 1 like
SynonymsARP6|CDA12|HSPC281|MSTP136|hARP6|hARPXSHIP164
Cytomap

12q23.1

12q23.1

Type of geneprotein-codingprotein-coding
Descriptionactin-related protein 6ARP6 actin related protein 6 homologUHRF1-binding protein 1-likeUHRF1 (ICBP90) binding protein 1-likesyntaxin 6Habc-interacting protein of 164 kDasyntaxin-6 Habc-interacting protein of 164 kDa
Modification date2020031320200313
UniProtAcc

Q9GZN1

Main function of 5'-partner protein:
.
Ensembl transtripts involved in fusion geneENST idsENST00000188312, ENST00000546902, 
ENST00000551617, ENST00000552376, 
ENST00000550813, 
ENST00000356828, 
ENST00000545232, ENST00000279907, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score4 X 4 X 2=328 X 7 X 6=336
# samples 49
** MAII scorelog2(4/32*10)=0.321928094887362
effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs).
DoF>8 and MAII>0
log2(9/336*10)=-1.90046432644909
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: ACTR6 [Title/Abstract] AND UHRF1BP1L [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: ACTR6 [Title/Abstract] AND UHRF1BP1L [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)ACTR6(100601564)-UHRF1BP1L(100433567), # samples:1
Anticipated loss of major functional domain due to fusion event.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr12:100601564/chr12:100433567)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across ACTR6 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across UHRF1BP1L (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000188312ACTR6chr12100601564+ENST00000279907UHRF1BP1Lchr12100433567-201811447651457230
ENST00000546902ACTR6chr12100601564+ENST00000279907UHRF1BP1Lchr12100433567-1430556231869212
ENST00000552376ACTR6chr12100601564+ENST00000279907UHRF1BP1Lchr12100433567-127540122714230
ENST00000551617ACTR6chr12100601564+ENST00000279907UHRF1BP1Lchr12100433567-1395521196834212

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000188312ENST00000279907ACTR6chr12100601564+UHRF1BP1Lchr12100433567-0.0011287320.99887127
ENST00000546902ENST00000279907ACTR6chr12100601564+UHRF1BP1Lchr12100433567-0.0037927980.99620724
ENST00000552376ENST00000279907ACTR6chr12100601564+UHRF1BP1Lchr12100433567-0.0007478350.99925214
ENST00000551617ENST00000279907ACTR6chr12100601564+UHRF1BP1Lchr12100433567-0.0030594030.9969406

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for ACTR6-UHRF1BP1L

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
ACTR6chr12100601564UHRF1BP1Lchr121004335671144126FEEYQFQAVLRVNDSHMLNTGNDLKE
ACTR6chr12100601564UHRF1BP1Lchr12100433567401126FEEYQFQAVLRVNDSHMLNTGNDLKE
ACTR6chr12100601564UHRF1BP1Lchr12100433567521108FEEYQFQAVLRVNDSHMLNTGNDLKE
ACTR6chr12100601564UHRF1BP1Lchr12100433567556108FEEYQFQAVLRVNDSHMLNTGNDLKE

Top

Potential FusionNeoAntigen Information of ACTR6-UHRF1BP1L in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
ACTR6-UHRF1BP1L_100601564_100433567.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144HLA-B39:01LRVNDSHML0.99630.7906918
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144HLA-B38:01LRVNDSHML0.98940.8574918
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144HLA-B38:02LRVNDSHML0.9880.8658918
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144HLA-C07:05LRVNDSHML0.99660.9515918
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144HLA-B39:12LRVNDSHML0.99540.798918
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144HLA-C07:95LRVNDSHML0.99360.6285918
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144HLA-C07:27LRVNDSHML0.99250.9473918
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144HLA-C07:13LRVNDSHML0.98830.9138918
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144HLA-C07:29LRVNDSHML0.9850.9204918
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144HLA-B39:05LRVNDSHML0.97140.7643918
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144HLA-C07:10LRVNDSHML0.91560.9564918
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144HLA-C07:67LRVNDSHML0.91020.9441918
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144HLA-C07:80LRVNDSHML0.91020.9441918
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144HLA-C07:46LRVNDSHML0.89840.8385918
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144HLA-C07:19LRVNDSHML0.89580.6727918
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144HLA-C12:16LRVNDSHML0.03210.9588918
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144HLA-B27:06LRVNDSHML0.99920.6826918
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144HLA-B27:08LRVNDSHML0.99910.8305918
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144HLA-B27:09LRVNDSHML0.99880.8897918
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144HLA-B39:31LRVNDSHML0.9960.7931918
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144HLA-C07:01LRVNDSHML0.99530.5786918
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144HLA-B38:05LRVNDSHML0.98940.8574918
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144HLA-C06:08LRVNDSHML0.96530.9882918
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144HLA-C07:02LRVNDSHML0.91020.9441918
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144HLA-C07:22LRVNDSHML0.86920.702918
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144HLA-B15:09LRVNDSHML0.80910.5746918
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144HLA-B15:30VLRVNDSHM0.80410.5193817
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144HLA-C06:17LRVNDSHML0.08630.9886918
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144HLA-C06:02LRVNDSHML0.08630.9886918

Top

Potential FusionNeoAntigen Information of ACTR6-UHRF1BP1L in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
ACTR6-UHRF1BP1L_100601564_100433567.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0338QAVLRVNDSHMLNTG621
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0338FQAVLRVNDSHMLNT520
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0801EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0801EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0801FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0803EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0803EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0803FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0805EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0805EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0805FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0808EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0808EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0808FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0811EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0811EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0811FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0814EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0814EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0814FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0816EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0816EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0816FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0818EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0818EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0818FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0823EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0823EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0823FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0826EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0826EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0826FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0827EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0827EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0827FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0829EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0829EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0829FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0832EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0833EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0833EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0833FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0835EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0835EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0835FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0836EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0836EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0836FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0837EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0837EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0837FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0838EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0838EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0838FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0839EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0839EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0839FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0840EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0840EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-0840FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1303EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1303EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1303FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-13100EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-13101EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-13101EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-13101FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1310EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1310EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1310FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1312EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1312EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1312FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1313EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1313EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1313FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1321EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1321EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1321FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1330EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1330EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1330FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1333EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1333EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1333FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1338EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1338EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1346EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1349EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1349EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1349FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1355EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1355EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1355FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1365EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1365EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1366EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1366EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1366FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1388EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1388EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1388FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1390EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1390EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1390FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1395EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1395EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1395FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1407EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1413EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1413EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1413FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1414EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1414EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1422EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1422EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1422FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1425EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1425EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1425FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1436EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1436EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1444EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1444EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1447QAVLRVNDSHMLNTG621
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1448QAVLRVNDSHMLNTG621
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1453EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1453EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1453FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1463EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1463EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1463FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1468EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1469EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1469EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1469FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1485EEYQFQAVLRVNDSH116
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1485EYQFQAVLRVNDSHM217
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1485FEEYQFQAVLRVNDS015
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1525QAVLRVNDSHMLNTG621
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB1-1525FQAVLRVNDSHMLNT520
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0109QAVLRVNDSHMLNTG621
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0201QAVLRVNDSHMLNTG621
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0201FQAVLRVNDSHMLNT520
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0201QFQAVLRVNDSHMLN419
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0202QAVLRVNDSHMLNTG621
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0202FQAVLRVNDSHMLNT520
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0204QAVLRVNDSHMLNTG621
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0204FQAVLRVNDSHMLNT520
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0204QFQAVLRVNDSHMLN419
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0204AVLRVNDSHMLNTGN722
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0205QAVLRVNDSHMLNTG621
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0205FQAVLRVNDSHMLNT520
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0209QAVLRVNDSHMLNTG621
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0209FQAVLRVNDSHMLNT520
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0210QAVLRVNDSHMLNTG621
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0210FQAVLRVNDSHMLNT520
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0211QAVLRVNDSHMLNTG621
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0211FQAVLRVNDSHMLNT520
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0212QAVLRVNDSHMLNTG621
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0212FQAVLRVNDSHMLNT520
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0213QAVLRVNDSHMLNTG621
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0214QAVLRVNDSHMLNTG621
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0214FQAVLRVNDSHMLNT520
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0215QAVLRVNDSHMLNTG621
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0216QAVLRVNDSHMLNTG621
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0216FQAVLRVNDSHMLNT520
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0216QFQAVLRVNDSHMLN419
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0217QAVLRVNDSHMLNTG621
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0218QAVLRVNDSHMLNTG621
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0218FQAVLRVNDSHMLNT520
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0219QAVLRVNDSHMLNTG621
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0219FQAVLRVNDSHMLNT520
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0220QAVLRVNDSHMLNTG621
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0220FQAVLRVNDSHMLNT520
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0221QAVLRVNDSHMLNTG621
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0221FQAVLRVNDSHMLNT520
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0222QAVLRVNDSHMLNTG621
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0222FQAVLRVNDSHMLNT520
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0223QAVLRVNDSHMLNTG621
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0223FQAVLRVNDSHMLNT520
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0224QAVLRVNDSHMLNTG621
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0224FQAVLRVNDSHMLNT520
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0224QFQAVLRVNDSHMLN419
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0225QAVLRVNDSHMLNTG621
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0225FQAVLRVNDSHMLNT520
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0301QAVLRVNDSHMLNTG621
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0301FQAVLRVNDSHMLNT520
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0301QFQAVLRVNDSHMLN419
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0301AVLRVNDSHMLNTGN722
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0303QAVLRVNDSHMLNTG621
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0303FQAVLRVNDSHMLNT520
ACTR6-UHRF1BP1Lchr12100601564chr121004335671144DRB3-0303QFQAVLRVNDSHMLN419

Top

Fusion breakpoint peptide structures of ACTR6-UHRF1BP1L

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
7161QAVLRVNDSHMLNTACTR6UHRF1BP1Lchr12100601564chr121004335671144

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of ACTR6-UHRF1BP1L

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN7161QAVLRVNDSHMLNT-7.15543-7.26883
HLA-B14:023BVN7161QAVLRVNDSHMLNT-4.77435-5.80965
HLA-B52:013W397161QAVLRVNDSHMLNT-6.80875-6.92215
HLA-B52:013W397161QAVLRVNDSHMLNT-4.20386-5.23916
HLA-A11:014UQ27161QAVLRVNDSHMLNT-7.5194-8.5547
HLA-A11:014UQ27161QAVLRVNDSHMLNT-6.9601-7.0735
HLA-A24:025HGA7161QAVLRVNDSHMLNT-7.52403-7.63743
HLA-A24:025HGA7161QAVLRVNDSHMLNT-5.82433-6.85963
HLA-B27:056PYJ7161QAVLRVNDSHMLNT-3.28285-4.31815
HLA-B44:053DX87161QAVLRVNDSHMLNT-5.91172-6.94702
HLA-B44:053DX87161QAVLRVNDSHMLNT-4.24346-4.35686

Top

Vaccine Design for the FusionNeoAntigens of ACTR6-UHRF1BP1L

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
ACTR6-UHRF1BP1Lchr12100601564chr12100433567817VLRVNDSHMTATTAAGAGTAAATGATTCTCACATGC
ACTR6-UHRF1BP1Lchr12100601564chr12100433567918LRVNDSHMLTAAGAGTAAATGATTCTCACATGCTTA

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
ACTR6-UHRF1BP1Lchr12100601564chr12100433567015FEEYQFQAVLRVNDSTTGAAGAATACCAGTTTCAAGCAGTATTAAGAGTAAATGATTCTC
ACTR6-UHRF1BP1Lchr12100601564chr12100433567116EEYQFQAVLRVNDSHAAGAATACCAGTTTCAAGCAGTATTAAGAGTAAATGATTCTCACA
ACTR6-UHRF1BP1Lchr12100601564chr12100433567217EYQFQAVLRVNDSHMAATACCAGTTTCAAGCAGTATTAAGAGTAAATGATTCTCACATGC
ACTR6-UHRF1BP1Lchr12100601564chr12100433567419QFQAVLRVNDSHMLNAGTTTCAAGCAGTATTAAGAGTAAATGATTCTCACATGCTTAACA
ACTR6-UHRF1BP1Lchr12100601564chr12100433567520FQAVLRVNDSHMLNTTTCAAGCAGTATTAAGAGTAAATGATTCTCACATGCTTAACACTG
ACTR6-UHRF1BP1Lchr12100601564chr12100433567621QAVLRVNDSHMLNTGAAGCAGTATTAAGAGTAAATGATTCTCACATGCTTAACACTGGAA
ACTR6-UHRF1BP1Lchr12100601564chr12100433567722AVLRVNDSHMLNTGNCAGTATTAAGAGTAAATGATTCTCACATGCTTAACACTGGAAATG

Top

Information of the samples that have these potential fusion neoantigens of ACTR6-UHRF1BP1L

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
STADACTR6-UHRF1BP1Lchr12100601564ENST00000188312chr12100433567ENST00000279907TCGA-CG-5717-01A

Top

Potential target of CAR-T therapy development for ACTR6-UHRF1BP1L

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to ACTR6-UHRF1BP1L

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to ACTR6-UHRF1BP1L

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource